How to Match CGT Manufacturing Models to Pipeline Needs

This opening segment of Cell & Gene Live, How CGT Developers Can Choose the Right Manufacturing Model for Their Pipeline, features Omkar Kawalekar, Ph.D., Manufacturing & Supply Chain Lead, Deloitte Consulting and Zoe Zheng, Executive Director, Pipeline Technical and Strategic Lead, Legend Biotech discussing how early manufacturing decisions shape scalability and commercialization. The conversation highlights common pitfalls, such as treating manufacturing as a facilities decision rather than an operating model. They also explore key considerations in centralized vs. decentralized models, including process complexity, patient needs, and maintaining quality and consistency at scale.